The ATAGI approval of Moderna Spikevax for the primary vaccination of children 6-11 years provides more options for families and pharmacists. Read the ATAGI statement.
Key points include:
There is NO paediatric formulation. It is the same Moderna Spikevax formulation used for patients 12 years and older.
The dose is 50µg (0.25ml) for children 6-11 years i.e. HALF the primary dose for patients 12 years and over.
The dose is the same as the booster dose (50µg – 0.25ml) approved for people 18 years and over (at time of publication).
The recommended schedule for Modern…
